Kronos Bio, Inc. (KRON) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1247846,
    "name": "Kronos Bio, Inc.",
    "stock_name": "Kronos Bio, Inc.",
    "full_name": "Kronos Bio, Inc.",
    "name_url": "stocks-analysis/kronos-bio-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "0.88",
    "chg": 0.01,
    "chgp": "1.49%",
    "dir": 1,
    "prev_price": "0.87",
    "mcapval": "53.65",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US50107A1043",
    "curr_date": "Jun 20",
    "curr_time": "",
    "bse_nse_vol": "108.18 k",
    "exc_status": "Active",
    "traded_date": "Jun 20, 2025",
    "traded_date_str": "2025 06 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kronos-bio-inc-1247846-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Kronos Bio, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kronos-bio-inc-technically-bullish-or-bearish-3547932",
        "imagepath": "",
        "date": "2025-09-20 20:06:14",
        "description": "As of 3 June 2025, the technical trend for Kronos Bio, Inc. has changed from bearish to mildly bearish. The weekly MACD is mildly bullish, while the monthly MACD is also mildly bullish, suggesting some positive momentum. However, the daily moving averages indicate a mildly bearish stance. The Bollinger Bands show a mixed signal with a mildly bullish weekly outlook and a mildly bearish monthly outlook. The KST is bearish on the weekly and mildly bullish on the monthly, and the Dow Theory indicates a bearish monthly trend with no trend on the weekly. The OBV is mildly bullish weekly but mildly bearish monthly.\n\nIn terms of performance, Kronos Bio has underperformed the S&P 500 across most periods, with a 1-week return of -1.41% compared to the S&P 500's 1.05%, and a 1-year return of -15.38% against the S&P 500's 17.14%. Overall, the technical stance is mildly bearish, driven by mixed indicators and significan..."
      },
      {
        "title": "Is Kronos Bio, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kronos-bio-inc-overvalued-or-undervalued-3544145",
        "imagepath": "",
        "date": "2025-09-20 18:39:00",
        "description": "As of 10 May 2023, the valuation grade for Kronos Bio, Inc. has moved from does not qualify to risky, indicating increased caution regarding its financial health. Based on the available metrics, the company appears to be overvalued. The price-to-book value stands at 0.67, while the EV to EBITDA ratio is 0.88, suggesting that the market may not be pricing in the company's significant losses adequately. Additionally, the return on capital employed (ROCE) is exceptionally high at 310.76%, but this is somewhat misleading given the negative return on equity (ROE) of -56.07%.\n\nIn comparison to its peers, Kronos Bio, Inc. has a valuation of -1.1990, while Chimerix, Inc. is at -8.6897, and CytomX Therapeutics, Inc. is rated very attractive with a P/E of 7.4924. This highlights that Kronos is not only underperforming relative to a more attractive competitor but also suggests that its current valuation may not be jus..."
      }
    ],
    "total": 7,
    "sid": "1247846",
    "stock_news_url": "https://www.marketsmojo.com/news/kronos-bio-inc-1247846"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Kronos Bio, Inc. technically bullish or bearish?

2025-09-20 20:06:14

As of 3 June 2025, the technical trend for Kronos Bio, Inc. has changed from bearish to mildly bearish. The weekly MACD is mildly bullish, while the monthly MACD is also mildly bullish, suggesting some positive momentum. However, the daily moving averages indicate a mildly bearish stance. The Bollinger Bands show a mixed signal with a mildly bullish weekly outlook and a mildly bearish monthly outlook. The KST is bearish on the weekly and mildly bullish on the monthly, and the Dow Theory indicates a bearish monthly trend with no trend on the weekly. The OBV is mildly bullish weekly but mildly bearish monthly. In terms of performance, Kronos Bio has underperformed the S&P 500 across most periods, with a 1-week return of -1.41% compared to the S&P 500's 1.05%, and a 1-year return of -15.38% against the S&P 500's 17.14%. Overall, the technical stance is mildly bearish, driven by mixed indicators and significan...

Is Kronos Bio, Inc. overvalued or undervalued?

2025-09-20 18:39:00

As of 10 May 2023, the valuation grade for Kronos Bio, Inc. has moved from does not qualify to risky, indicating increased caution regarding its financial health. Based on the available metrics, the company appears to be overvalued. The price-to-book value stands at 0.67, while the EV to EBITDA ratio is 0.88, suggesting that the market may not be pricing in the company's significant losses adequately. Additionally, the return on capital employed (ROCE) is exceptionally high at 310.76%, but this is somewhat misleading given the negative return on equity (ROE) of -56.07%. In comparison to its peers, Kronos Bio, Inc. has a valuation of -1.1990, while Chimerix, Inc. is at -8.6897, and CytomX Therapeutics, Inc. is rated very attractive with a P/E of 7.4924. This highlights that Kronos is not only underperforming relative to a more attractive competitor but also suggests that its current valuation may not be jus...

View All News